Your browser doesn't support javascript.
loading
Corrigendum to "Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma" [Int. Immunopharmacol. 130 (2024) 111510].
Liu, Hong; Gan, Xue-Mei; Sun, Jian-Ming; Yang, Qin; Zhang, Dai-Zhong; Zuo, YongQing; Liu, Feng-Ling; Li, Bo; Tan, Qi-Liang; Zhang, Jun.
Afiliação
  • Liu H; Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China; Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Luzhou 646000, China.
  • Gan XM; Department of Hepatology, Dazhou Central Hospital, Dazhou 635000, China.
  • Sun JM; Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China.
  • Yang Q; Department of Hepatology, Dazhou Central Hospital, Dazhou 635000, China.
  • Zhang DZ; Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China.
  • Zuo Y; Department of Hepatology, Dazhou Central Hospital, Dazhou 635000, China.
  • Liu FL; Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China.
  • Li B; Department of General Surgery (Hepatopancreatobiliary Surgery), The Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Luzhou 646000, China.
  • Tan QL; Department of Hepatology, Dazhou Central Hospital, Dazhou 635000, China.
  • Zhang J; Department of Hepatobiliary Surgery, Dazhou Central Hospital, Dazhou 635000, China. Electronic address: junz18572@126.com.
Int Immunopharmacol ; 137: 112494, 2024 Aug 20.
Article em En | MEDLINE | ID: mdl-38902130
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2024 Tipo de documento: Article